iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
iRadimed (IRMD) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $20.73 M
According to iRadimed's latest financial reports the company's total liabilities are $20.73 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
iRadimed - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $20.73 M | 75.12% |
| 2022-12-31 | $11.84 M | 10.58% |
| 2021-12-31 | $10.7 M | 10.59% |
| 2020-12-31 | $9.68 M | -13.59% |
| 2019-12-31 | $11.2 M | 72.47% |
| 2018-12-31 | $6.49 M | 6.82% |
| 2017-12-31 | $6.08 M | 14.63% |
| 2016-12-31 | $5.3 M | 60.23% |
| 2015-12-31 | $3.31 M | 36.88% |
| 2014-12-31 | $2.41 M | 54.66% |
| 2013-12-31 | $1.56 M | -32.99% |
| 2012-12-31 | $2.33 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | $2.64 B | 12,649.87% | 🇺🇸 USA |
 NuVasive NUVA | $1.19 B | 5,672.65% | 🇺🇸 USA |
 DexCom DXCM | $4.23 B | 20,325.45% | 🇺🇸 USA |
 AtriCure ATRC | $0.14 B | 612.60% | 🇺🇸 USA |